A director at United Security Bancshares bought 55,814 shares at 8.337USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Treace Medical Concepts Reports Second Quarter 2025 Financial Results Announces Full Market Release of Three New Bunion Technologies PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the second quarter ended June 30, 2025. Recent Highlights Generated revenue of $47.4 million in second quarter 2025 representing growth of 7% over the same period in...
CompoSecure Reports Record Second Quarter 2025 Financial Results Operating results exceed expectations across all key metricsStrong top line growth driven by domestic programs from traditional banks and fintechsRecord profitability demonstrates early results from CompoSecure Operating SystemRaising previously issued full-year 2025 guidance SOMERSET, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its financial and operating results for the second quarter ended June 30, 2025. “Our strong sec...
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced plans to host an investor day at 9:00 am E.T. on September 3, 2025, in New York, New York. The event will include presentations by members of management and experienced surgeon users, highlighting their experiences with the expanded technol...
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the peer-reviewed publication of the four-year interim results from its ALIGN3D™ multicenter prospective study demonstrating positive clinical and radiographic outcomes of the Lapiplasty® Proc...
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025 PONTE VEDRA, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, August 7, 2025. Company management will host a conference call to discuss financial results beginning at ...
CompoSecure Schedules Second Quarter 2025 Conference Call for August 7th at 5:00 p.m. ET SOMERSET, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Thursday, August 7, 2025, at 5:00 p.m. Eastern Daylight Time (EDT) to discuss its financial results for the second quarter ended June 30, 2025. The Company’s results will be reported in a press release prior to the call. CompoSecure’s Executive Chairman David Cote, President & CEO Jon Wilk, and CFO Tim Fitzsimmons will host the c...
CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of two new members to its Board of Directors (“Board”). Effective July 12, 2025, Kevin M. Moriarty and Rebecca K. Corbin Loree have joined the company as independent directors. “We’re excited to welcome Kevin and Rebecca to our Board of Directors. Their deep financial and capital markets expertise will ...
CompoSecure Wins Four Prestigious ICMA Élan Awards for its Innovative Card Design Leading metal card manufacturer takes home six honors for products from all over the world SOMERSET, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced it was a winner of the prestigious 2025 Élan Award of Excellence by the (ICMA). The company won four awards in this year’s program: “Feature Card – Metal” and “Best Regional Card – North American” categories for the metal card - The falcon symbolizes strength,...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
CompoSecure Announces CFO Retirement; Reaffirms Previously Issued Full Year 2025 Guidance CompoSecure announces that Tim Fitzsimmons, its Chief Financial Officer, will retire from his position once a successor has been named and assumes the role, which is anticipated to occur in the second half of 2025, but no later than January 1, 2026.A comprehensive search will be launched for a CFO successor; Mr. Fitzsimmons will serve as a consultant commencing on his retirement date and through January 1, 2027 to ensure a smooth transition.CompoSecure reaffirms its previously issued full year 2025 gui...
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, “Zimmer”) (NYSE: ZBH), alleging infringement of 4 patents related to Treace’s innovativ...
CompoSecure Reports First Quarter 2025 Financial Results Operating results in line with expectationsReiterating previously issued full-year 2025 guidanceCompleted spin-off of Resolute Holdings Management, Inc. (Nasdaq: RHLD)Accounting standards related to the spin-off require the Company to report results using equity method of accounting in accordance with U.S. GAAPNon-GAAP results are also included below and provide a clearer picture of the underlying financial performance of the operating business consistent with historical reporting SOMERSET, N.J., May 12, 2025 (GLOBE NEWSWIR...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.